Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition

Open access
Reich, Siegfried H., Sprengeler, Paul A., Chiang, Gary G., Appleman, James R., Chen, Joan, Clarine, Jeff, Eam, Boreth, Ernst, Justin T., Han, Qing, Goel, Vikas K., Han, Edward Z. R., Huang, Vera, Hung, Ivy N. J., Jemison, Adrianna, Jessen, Katti A., Molter, Jolene, Murphy, Douglas, Neal, Melissa, Parker, Gregory S., Shaghafi, Michael, Sperry, Samuel, Staunton, Jocelyn, Stumpf, Craig R., Thompson, Peggy A., Tran, Chinh, Webber, Stephen E., Wegerski, Christopher J., Zheng, Hong, Webster, Kevin R. · 2018 · Journal of Medicinal Chemistry

Abstract

Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated protein kinase interacting kinases (MNK)1/2 are key regulators of mRNA translation integrating signals from oncogenic and immune signaling pathways through phosphorylation of eIF4E and other mRNA binding proteins. Modulation of these key effector proteins regulates mRNA, which controls tumor/stromal cell signaling. Compound 23 (eFT508), an exquisitely selective, potent dual MNK1/2 inhibitor, was designed to assess the potential for control of oncogene signaling at the level of mRNA translation. The crystal structure-guided design leverages stereoelectronic interactions unique to MNK culminating in a novel pyridone-aminal structure described for the first time in the kinase literature. Compound 23 has potent in vivo antitumor activity in models of diffuse large cell B-cell lymphoma and solid tumors, suggesting that controlling dysregulated translation has real therapeutic potential. Compound 23 is currently being evaluated in Phase 2 clinical trials in solid tumors and lymphoma. Compound 23 is the first highly selective dual MNK inhibitor targeting dysregulated translation being assessed clinically.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.7b01795

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 175

Metadata

Authors
Reich, S. H., Sprengeler, P. A., Chiang, G. G., Appleman, J. R., Chen, J., Clarine, J., Eam, B., Ernst, J. T., Han, Q., Goel, V. K., Han, E. Z. R., Huang, V., Hung, I. N. J., Jemison, A., Jessen, K. A., Molter, J., Murphy, D., Neal, M., Parker, G. S., Shaghafi, M., Sperry, S., Staunton, J., Stumpf, C. R., Thompson, P. A., Tran, C., Webber, S. E., Wegerski, C. J., Zheng, H., & Webster, K. R.
Venue
Journal of Medicinal Chemistry
Published
2018-03-10
Volume
61
Issue
8
Pages
3516-3540
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2793387915
Cited by
175
References
7
FWCI
6.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.